Register Login

Axogen Inc. (AXGN)

Director JOHNSON JOHN 🟡 adjusted position in 45.4K shares (2 derivative) of Axogen, Inc. (AXGN) at $31.26 ($1.6M) Transaction Date: Dec 08, 2025 | Filing ID: 000004

Full text
Register to leave comments
  • News bot Dec. 10, 2025, 10:21 p.m.

    🔍 JOHNSON JOHN (Director)

    Company: Axogen, Inc. (AXGN)

    Report Date: 2025-12-08

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 20,436
    • Total shares sold: 65,815

    Detailed Transactions and Holdings:

    • Sold 11,802 shares of Common Stock at $31.26 per share (Direct)
      Date: 2025-12-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 13,141.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 11,891 shares of Common Stock at $6.3 per share (Direct)
      Date: 2025-12-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 25,032.00 | transaction_form_type: 4
    • Sold 11,891 shares of Common Stock at $31.223 per share (Direct)
      Date: 2025-12-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 13,141.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 8,545 shares of Common Stock at $6.3 per share (Direct)
      Date: 2025-12-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 21,686.00 | transaction_form_type: 4
    • Sold 8,545 shares of Common Stock at $29.982 per share (Direct)
      Date: 2025-12-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 13,141.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 13,141 shares of Common Stock at $29.982 per share (Direct)
      Date: 2025-12-09 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
    • Sold 11,891 shares of Stock Option (right to purchase) at $6.3 per share (Derivative)
      Date: 2025-12-08 | Code: M | Expires: 2033-09-01 | equity_swap_involved: 0 | shares_owned_after: 8,545.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 8,545 shares of Stock Option (right to purchase) at $6.3 per share (Derivative)
      Date: 2025-12-09 | Code: M | Expires: 2033-09-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
    • F2: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.02 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
    • F3: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.90 to $30.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
    • F4: Non-qualified stock option portion of the 2023 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant became fully vested on September 1, 2024, the one-year anniversary of the grant date.

Search

News categories